Another one say generic Arixtra had about 10% in Early Nov.
http://www.financialexpress.com/news/booster-from-bulk-drugs/871959/3
Dr Reddy's Lab-Rating: Overweight
Booster from bulk drugs
Posted: Monday, Nov 07, 2011 at 0618 hrs IST
Tags: HSBC | SG&A Growth | Drug-maker | OTC
under the head of raw materials.
Fondaparinux (generic Arixtra) has a current US market share of about 10% and the company expects it to garner more market share after the scaling up of the manufacturing capacity and the addressing of the packaging issues.
Another one say generic Arixtra had about 10% in Early...
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable